SG55296A1 - Phenylethalolaminotetralincarboxamide derivatives - Google Patents
Phenylethalolaminotetralincarboxamide derivativesInfo
- Publication number
- SG55296A1 SG55296A1 SG1997001031A SG1997001031A SG55296A1 SG 55296 A1 SG55296 A1 SG 55296A1 SG 1997001031 A SG1997001031 A SG 1997001031A SG 1997001031 A SG1997001031 A SG 1997001031A SG 55296 A1 SG55296 A1 SG 55296A1
- Authority
- SG
- Singapore
- Prior art keywords
- carbon atom
- configuration
- amino group
- agent
- marked
- Prior art date
Links
- 229910052799 carbon Inorganic materials 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000003277 amino group Chemical group 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 206010000242 Abortion threatened Diseases 0.000 abstract 1
- 206010007027 Calculus urinary Diseases 0.000 abstract 1
- 208000001871 Tachycardia Diseases 0.000 abstract 1
- 208000005985 Threatened Abortion Diseases 0.000 abstract 1
- 206010043508 Threatened labour Diseases 0.000 abstract 1
- 125000002723 alicyclic group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 abstract 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 230000006794 tachycardia Effects 0.000 abstract 1
- 208000008281 urolithiasis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12622596 | 1996-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG55296A1 true SG55296A1 (en) | 1998-12-21 |
Family
ID=14929861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1997001031A SG55296A1 (en) | 1996-04-12 | 1997-04-01 | Phenylethalolaminotetralincarboxamide derivatives |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6046192A (fr) |
| EP (1) | EP0893432B1 (fr) |
| JP (1) | JP4044615B2 (fr) |
| CN (1) | CN1100033C (fr) |
| AT (1) | ATE344792T1 (fr) |
| AU (1) | AU726686B2 (fr) |
| BR (1) | BR9708642A (fr) |
| CZ (1) | CZ327598A3 (fr) |
| DE (1) | DE69736924T2 (fr) |
| EA (1) | EA001108B1 (fr) |
| ES (1) | ES2275284T3 (fr) |
| ID (1) | ID19038A (fr) |
| MY (1) | MY118678A (fr) |
| NO (1) | NO984699L (fr) |
| NZ (1) | NZ332212A (fr) |
| PL (1) | PL188158B1 (fr) |
| SG (1) | SG55296A1 (fr) |
| TW (1) | TW448143B (fr) |
| WO (1) | WO1997038970A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1276911C (zh) * | 2001-09-30 | 2006-09-27 | 沈阳药科大学 | 具有β2－受体兴奋作用的新型苯乙醇胺类化合物及其制法 |
| WO2008102790A1 (fr) | 2007-02-21 | 2008-08-28 | Kissei Pharmaceutical Co., Ltd. | Composition pharmaceutique pour la prévention ou le traitement d'une maladie associée à la réduction des larmes |
| EP2098511A1 (fr) | 2008-03-07 | 2009-09-09 | Solvias AG | Procédé pour la préparation de composés contenant une structure d'hydronaphtalène avec un cycle benzène à substitution asymétrique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9107827D0 (en) * | 1991-04-12 | 1991-05-29 | Fujisawa Pharmaceutical Co | New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
| WO1993018007A1 (fr) * | 1992-03-13 | 1993-09-16 | Tokyo Tanabe Company Limited | Nouveau derive de carbostyrile |
| WO1999009001A1 (fr) * | 1997-08-19 | 1999-02-25 | Kissei Pharmaceutical Co., Ltd. | Derives de phenylethanolaminotetraline et bronchodilatateurs |
-
1997
- 1997-04-01 SG SG1997001031A patent/SG55296A1/en unknown
- 1997-04-03 MY MYPI97001450A patent/MY118678A/en unknown
- 1997-04-04 US US09/155,478 patent/US6046192A/en not_active Expired - Fee Related
- 1997-04-04 NZ NZ332212A patent/NZ332212A/xx unknown
- 1997-04-04 AU AU21783/97A patent/AU726686B2/en not_active Ceased
- 1997-04-04 ES ES97914598T patent/ES2275284T3/es not_active Expired - Lifetime
- 1997-04-04 EA EA199800920A patent/EA001108B1/ru not_active IP Right Cessation
- 1997-04-04 DE DE69736924T patent/DE69736924T2/de not_active Expired - Fee Related
- 1997-04-04 PL PL97329315A patent/PL188158B1/pl not_active IP Right Cessation
- 1997-04-04 AT AT97914598T patent/ATE344792T1/de not_active IP Right Cessation
- 1997-04-04 JP JP53693397A patent/JP4044615B2/ja not_active Expired - Fee Related
- 1997-04-04 CN CN97194877A patent/CN1100033C/zh not_active Expired - Fee Related
- 1997-04-04 EP EP97914598A patent/EP0893432B1/fr not_active Expired - Lifetime
- 1997-04-04 BR BR9708642A patent/BR9708642A/pt not_active Application Discontinuation
- 1997-04-04 CZ CZ983275A patent/CZ327598A3/cs unknown
- 1997-04-04 WO PCT/JP1997/001159 patent/WO1997038970A1/fr not_active Ceased
- 1997-04-10 TW TW086104755A patent/TW448143B/zh not_active IP Right Cessation
- 1997-04-11 ID IDP971211A patent/ID19038A/id unknown
-
1998
- 1998-10-08 NO NO984699A patent/NO984699L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ327598A3 (cs) | 1999-01-13 |
| DE69736924T2 (de) | 2007-03-01 |
| TW448143B (en) | 2001-08-01 |
| JP4044615B2 (ja) | 2008-02-06 |
| ID19038A (id) | 1998-06-04 |
| NO984699L (no) | 1998-12-11 |
| CN1100033C (zh) | 2003-01-29 |
| AU2178397A (en) | 1997-11-07 |
| EP0893432A4 (fr) | 2002-01-02 |
| AU726686B2 (en) | 2000-11-16 |
| CN1219926A (zh) | 1999-06-16 |
| US6046192A (en) | 2000-04-04 |
| EA001108B1 (ru) | 2000-10-30 |
| EA199800920A1 (ru) | 1999-04-29 |
| NO984699D0 (no) | 1998-10-08 |
| PL188158B1 (pl) | 2004-12-31 |
| BR9708642A (pt) | 1999-08-03 |
| EP0893432A1 (fr) | 1999-01-27 |
| PL329315A1 (en) | 1999-03-15 |
| MY118678A (en) | 2005-01-31 |
| ES2275284T3 (es) | 2007-06-01 |
| NZ332212A (en) | 1999-08-30 |
| ATE344792T1 (de) | 2006-11-15 |
| DE69736924D1 (en) | 2006-12-21 |
| EP0893432B1 (fr) | 2006-11-08 |
| WO1997038970A1 (fr) | 1997-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0372466A3 (fr) | 2-Amino-4- ou 5-méthoxycyclohexyl amides utilisables comme analgésiques | |
| EP2201945A3 (fr) | Utilisation de 2-aminoacétamides substitués pour le traitement ou l'amélioration de l'anxiété | |
| UA66825C2 (uk) | Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності | |
| CA2215013A1 (fr) | Indole-3-glyoxylamides n-substitues ayant un effet anti-asthmatique, antiallergique et immunosuppresseur et/ou immunomodulateur | |
| NZ218936A (en) | Peptidylaminodiols and pharmaceutical compositions | |
| DE3854454D1 (de) | Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung. | |
| LU91406I2 (fr) | Anidulafungine, optionnellement sous forme d'un sel pharmaceutiquement acceptable -ECALTA | |
| ES8801245A1 (es) | Un procedimiento para preparar derivados de piperidina | |
| HUT65351A (en) | Process for preparing ethanolamine derivatives haring sympathominetic and anti-pollakiuria activity and pharmaceutical compositions containing them as active agent | |
| AU2001497A (en) | 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives | |
| AU2176197A (en) | 3,4-disubstituted phenylethanolaminotetralincarboxylate derivatives | |
| DE69736924D1 (en) | Phenylethanolaminotetralincarboxamid-derivate | |
| WO1999005103A3 (fr) | Derives d'amidino-camptothecine | |
| EP0153755A3 (fr) | Composés pour le traitement de l'hypertension | |
| CA2251090A1 (fr) | Derives de phenylethanolaminotetralincarboxamide | |
| CA2270026A1 (fr) | Derives bicycliques substitues pour le traitement des troubles du systeme nerveux central | |
| EP1600452A3 (fr) | Synthèse de 2'-déoxy-L-nucléosides | |
| RU94016876A (ru) | Производные имидазо (5,1-с) (1,4) бензоксазин-1-она, способ их получения, фармацевтическая композиция и промежуточные соединения |